JP2012524070A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012524070A5 JP2012524070A5 JP2012505953A JP2012505953A JP2012524070A5 JP 2012524070 A5 JP2012524070 A5 JP 2012524070A5 JP 2012505953 A JP2012505953 A JP 2012505953A JP 2012505953 A JP2012505953 A JP 2012505953A JP 2012524070 A5 JP2012524070 A5 JP 2012524070A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- enyl
- dimethyl
- compound
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims description 30
- -1 4,8-dimethyl-non-1-enyl group Chemical group 0.000 claims description 27
- 239000008194 pharmaceutical composition Substances 0.000 claims description 9
- 206010028980 Neoplasm Diseases 0.000 claims description 8
- 201000011510 cancer Diseases 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 230000021164 cell adhesion Effects 0.000 claims description 3
- 230000001419 dependent effect Effects 0.000 claims description 3
- 230000002401 inhibitory effect Effects 0.000 claims description 3
- 125000002560 nitrile group Chemical group 0.000 claims description 3
- 208000037819 metastatic cancer Diseases 0.000 claims description 2
- 208000011575 metastatic malignant neoplasm Diseases 0.000 claims description 2
- 150000002825 nitriles Chemical class 0.000 claims description 2
- 239000000203 mixture Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17031609P | 2009-04-17 | 2009-04-17 | |
| US61/170,316 | 2009-04-17 | ||
| PCT/US2010/031363 WO2010121111A1 (en) | 2009-04-17 | 2010-04-16 | Antiadhesion agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012524070A JP2012524070A (ja) | 2012-10-11 |
| JP2012524070A5 true JP2012524070A5 (cg-RX-API-DMAC7.html) | 2013-03-28 |
Family
ID=42981455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012505953A Pending JP2012524070A (ja) | 2009-04-17 | 2010-04-16 | 抗接着剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8362071B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2418948B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2012524070A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2010236323A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2759011A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010121111A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2046315B1 (en) * | 2006-06-02 | 2013-04-10 | The Ohio State University Research Foundation | Therapeutic agents for the treatment of mantle cell lymphoma |
| WO2010120711A1 (en) * | 2009-04-13 | 2010-10-21 | The Ohio State University Research Foundation | Protein phosphatase 2a-activating agents |
| WO2010121111A1 (en) | 2009-04-17 | 2010-10-21 | The Ohio State University Research Foundation | Antiadhesion agents |
| WO2012074960A2 (en) | 2010-11-29 | 2012-06-07 | The Ohio State University Research Foundation | Fty720-derived anticancer agents |
| WO2013181488A2 (en) * | 2012-06-01 | 2013-12-05 | The Ohio State University Research Foundation | Inhibition of leukemic stem cells by pp2a activating agents |
| US20180092874A1 (en) * | 2016-10-03 | 2018-04-05 | Lincoln Memorial University | Identification and use of very long chain dicarboxylic acids for disease diagnosis, chemoprevention, and treatment |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2680749A (en) * | 1951-12-01 | 1954-06-08 | Eastman Kodak Co | Water-soluble tocopherol derivatives |
| DE2822324C3 (de) * | 1978-05-22 | 1981-02-26 | Basf Ag, 6700 Ludwigshafen | Herstellung von Vitamin-E-Trockenpulver |
| JPS59222415A (ja) | 1983-05-31 | 1984-12-14 | Kuraray Co Ltd | 免疫調節剤 |
| SK282225B6 (sk) * | 1995-12-28 | 2001-12-03 | Welfide Corporation | Použitie 2-amino-2[2-(4-oktylfenyl)etyl]-propán-1,3-diolu alebo jeho farmaceuticky prijateľnej adičnej soli s kyselinou na výrobu farmaceutického prostriedku |
| US6476004B1 (en) * | 1996-07-18 | 2002-11-05 | Mitsubishi Pharma Corporation | Pharmaceutical composition |
| JPH1180026A (ja) * | 1997-09-02 | 1999-03-23 | Yoshitomi Pharmaceut Ind Ltd | 新規免疫抑制剤、その使用方法およびその同定方法 |
| EP1115398B1 (en) * | 1998-09-23 | 2010-05-05 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| US6770672B1 (en) * | 1998-09-23 | 2004-08-03 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| US6703384B2 (en) * | 1998-09-23 | 2004-03-09 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| AU3680501A (en) * | 2000-02-11 | 2001-08-20 | Res Dev Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| EP1429755A4 (en) * | 2001-07-27 | 2004-08-11 | Univ Rochester | USE OF VITAMIN-E SUCCINATE AND ANTIANDROGEN COMBINATION |
| US6858227B1 (en) * | 2001-11-21 | 2005-02-22 | Sonus Pharmaceuticals, Inc. | Vitamin E conjugates |
| US20050215531A1 (en) * | 2002-05-16 | 2005-09-29 | Thomas Baumruker | Use of edg receptor binding agents in cancer |
| JP4861177B2 (ja) * | 2003-09-12 | 2012-01-25 | ニューロノバ エービー | 神経系の障害の処置 |
| CA2580584C (en) * | 2003-09-19 | 2015-07-28 | Galileo Pharmaceuticals, Inc. | Use of alpha-tocotrienol for treatment of mitochondrial diseases |
| CA2633374C (en) * | 2005-12-15 | 2013-10-01 | Mitsubishi Tanabe Pharma Corporation | Amine compound and use thereof for medical purposes |
| JP5256049B2 (ja) * | 2006-02-21 | 2013-08-07 | ザ オハイオ ステート ユニバーシティー リサーチ ファウンデーション | 抗癌剤 |
| EP2046315B1 (en) | 2006-06-02 | 2013-04-10 | The Ohio State University Research Foundation | Therapeutic agents for the treatment of mantle cell lymphoma |
| JP5216769B2 (ja) | 2006-08-17 | 2013-06-19 | ザ・ユニバーシティ・オブ・シカゴ | 炎症性疾患の処置 |
| BRPI0813683A2 (pt) * | 2007-06-14 | 2019-09-24 | Mitsubishi Tanabe Pharma Corp | composto amina e uso farmacêutico do mesmo |
| EP2344446A4 (en) | 2008-10-17 | 2012-04-04 | Akaal Pharma Pty Ltd | S1P RECEPTOR MODULATORS |
| WO2010120711A1 (en) * | 2009-04-13 | 2010-10-21 | The Ohio State University Research Foundation | Protein phosphatase 2a-activating agents |
| WO2010121111A1 (en) | 2009-04-17 | 2010-10-21 | The Ohio State University Research Foundation | Antiadhesion agents |
-
2010
- 2010-04-16 WO PCT/US2010/031363 patent/WO2010121111A1/en not_active Ceased
- 2010-04-16 AU AU2010236323A patent/AU2010236323A1/en not_active Abandoned
- 2010-04-16 US US12/761,504 patent/US8362071B2/en not_active Expired - Fee Related
- 2010-04-16 CA CA2759011A patent/CA2759011A1/en not_active Abandoned
- 2010-04-16 EP EP10765245.5A patent/EP2418948B1/en not_active Not-in-force
- 2010-04-16 JP JP2012505953A patent/JP2012524070A/ja active Pending